Theranos is laying off 41% of its staff
Theranos is experiencing another round of cutbacks. Bloomberg reports that the blood-testing organization is laying off 41% of its staff.
In October, Theranos shut its clinical labs, relinquishing around 340 individuals. This round will add another 155 individuals to that aggregate, with 220 staying, as indicated by Bloomberg.
Notwithstanding the cutbacks, Theranos likewise sold its Palo Alto workplaces, the San Francisco Business Times reported Wednesday.
The rest of the staff will concentrate on the organization's miniLab innovation.
Comments
Post a Comment